Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort

BACKGROUND: Atazanavir (ATV) not boosted by ritonavir (uATV) has been frequently used in the past for switching combination antiretroviral therapy (cART). However, the clinical outcomes and predictors of such strategy are unknown. METHODS: An observational study was carried out on the Italian MASTER...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:BMC Infect Dis
Główni autorzy: Postorino, Maria Concetta, Prosperi, Mattia, Focà, Emanuele, Quiros-Roldan, Eugenia, Di Filippo, Elisa, Maggiolo, Franco, Borghetti, Alberto, Ladisa, Nicoletta, Di Pietro, Massimo, Gori, Andrea, Sighinolfi, Laura, Pan, Angelo, Mazzini, Nicola, Torti, Carlo
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2017
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5353877/
https://ncbi.nlm.nih.gov/pubmed/28298195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2322-z
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy